ONC
BeiGene, Ltd.
356.00$
-0.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -60.1% | -41.3% | +498.0% | +52.7% | +3.7% | -51.6% | +228.9% | – | |
| – | +10.7% | +6.2% | -1.4% | +186.0% | -29.5% | -34.7% | +8.6% | +4.7% | +463.5% | -80.4% | +97.9% | – | |
| – | -3.2% | -4.5% | +47.3% | -12.2% | -6.2% | -11.3% | +58.0% | -6.6% | +437.7% | -83.7% | +111.4% | – | |
| – | – | -1,012.9% | – | – | -114.5% | – | – | +1,768.5% | +64.0% | -215.7% | – | – | |
| – | -8.4% | +15.7% | -43.0% | +21.6% | -30.8% | +25.9% | -45.2% | -24.7% | +494.9% | -85.7% | +66.9% | – | |
| – | -66.4% | +235.3% | -47.1% | +20.6% | -30.1% | +30.3% | -45.4% | -26.0% | -21.7% | +18.3% | +107.8% | – | |
| – | – | – | – | – | +274.0% | +629.4% | – | -116.3% | – | -36.1% | -133.7% | – | |
| – | – | -53.2% | -85.8% | -45.0% | -135.7% | +646.8% | – | +2,644.5% | -89.8% | -29.6% | -9.1% | – | |
| – | – | -460.2% | – | – | -178.2% | – | – | +418.4% | -62.3% | -51.1% | +175.2% | – | |
| – | – | – | – | – | -131.7% | – | – | +77.4% | -63.0% | +22.7% | +270.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.